335 related articles for article (PubMed ID: 15934845)
1. Dendritic cell fusion vaccines for cancer immunotherapy.
Rosenblatt J; Kufe D; Avigan D
Expert Opin Biol Ther; 2005 May; 5(5):703-15. PubMed ID: 15934845
[TBL] [Abstract][Full Text] [Related]
2. Dendritic/tumor fusion cells as cancer vaccines.
Avigan D; Rosenblatt J; Kufe D
Semin Oncol; 2012 Jun; 39(3):287-95. PubMed ID: 22595051
[TBL] [Abstract][Full Text] [Related]
3. Fusions of breast cancer and dendritic cells as a novel cancer vaccine.
Avigan D
Clin Breast Cancer; 2003 Feb; 3 Suppl 4():S158-63. PubMed ID: 12620154
[TBL] [Abstract][Full Text] [Related]
4. Immature dendritic cell/tumor cell fusions induce potent antitumour immunity.
Takeda A; Homma S; Okamoto T; Kufe D; Ohno T
Eur J Clin Invest; 2003 Oct; 33(10):897-904. PubMed ID: 14511362
[TBL] [Abstract][Full Text] [Related]
5. Cancer vaccine by fusions of dendritic and cancer cells.
Koido S; Hara E; Homma S; Namiki Y; Ohkusa T; Gong J; Tajiri H
Clin Dev Immunol; 2009; 2009():657369. PubMed ID: 20182533
[TBL] [Abstract][Full Text] [Related]
6. Dendritic/tumor fusion cell-based vaccination against cancer.
Koido S; Hara E; Homma S; Fujise K; Gong J; Tajiri H
Arch Immunol Ther Exp (Warsz); 2007; 55(5):281-7. PubMed ID: 18219758
[TBL] [Abstract][Full Text] [Related]
7. Cell fusion: from hybridoma to dendritic cell-based vaccine.
Gong J; Koido S; Calderwood SK
Expert Rev Vaccines; 2008 Sep; 7(7):1055-68. PubMed ID: 18767954
[TBL] [Abstract][Full Text] [Related]
8. Tumour cell-dendritic cell fusion for cancer immunotherapy: comparison of therapeutic efficiency of polyethylen-glycol versus electro-fusion protocols.
Lindner M; Schirrmacher V
Eur J Clin Invest; 2002 Mar; 32(3):207-17. PubMed ID: 11895473
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of dendritic-tumor fusion hybrids and their utility in cancer immunotherapy.
Shu S; Zheng R; Lee WT; Cohen PA
Crit Rev Immunol; 2007; 27(5):463-83. PubMed ID: 18197808
[TBL] [Abstract][Full Text] [Related]
10. Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells.
Cao X; Zhang W; Wang J; Zhang M; Huang X; Hamada H; Chen W
Immunology; 1999 Aug; 97(4):616-25. PubMed ID: 10457215
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cell-tumor fusion vaccines for renal cell carcinoma.
Avigan D
Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6347S-52S. PubMed ID: 15448029
[TBL] [Abstract][Full Text] [Related]
13. Cancer immunotherapy by fusions of dendritic cells and tumor cells.
Koido S; Hara E; Homma S; Ohkusa T; Gong J; Tajiri H
Immunotherapy; 2009 Jan; 1(1):49-62. PubMed ID: 20635973
[TBL] [Abstract][Full Text] [Related]
14. Engineered fusion hybrid vaccine of IL-18 gene-modified tumor cells and dendritic cells induces enhanced antitumor immunity.
Xia D; Li F; Xiang J
Cancer Biother Radiopharm; 2004 Jun; 19(3):322-30. PubMed ID: 15285878
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells as vectors for immunotherapy of cancer.
Paczesny S; Ueno H; Fay J; Banchereau J; Palucka AK
Semin Cancer Biol; 2003 Dec; 13(6):439-47. PubMed ID: 15001163
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cell-based cancer immunotherapy: potential for treatment of colorectal cancer?
Chen W; Rains N; Young D; Stubbs RS
J Gastroenterol Hepatol; 2000 Jul; 15(7):698-705. PubMed ID: 10937673
[TBL] [Abstract][Full Text] [Related]
17. Cancer immunotherapy using dendritic/tumour-fusion vaccine induces elevation of serum anti-nuclear antibody with better clinical responses.
Homma S; Sagawa Y; Ito M; Ohno T; Toda G
Clin Exp Immunol; 2006 Apr; 144(1):41-7. PubMed ID: 16542363
[TBL] [Abstract][Full Text] [Related]
18. Current status and future perspectives of dendritic cell-based cancer immunotherapy.
H Yi D; Appel S
Scand J Immunol; 2013 Aug; 78(2):167-71. PubMed ID: 23672402
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic vaccine generated by electrofusion of dendritic cells and tumour cells.
Kuriyama H; Shimizu K; Lee W; Kjaergaard J; Parkhurst MR; Cohen PA; Shu S
Dev Biol (Basel); 2004; 116():169-78; discussion 179-86. PubMed ID: 15603192
[TBL] [Abstract][Full Text] [Related]
20. Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myeloma.
Raje N; Hideshima T; Davies FE; Chauhan D; Treon SP; Young G; Tai YT; Avigan D; Gong J; Schlossman RL; Richardson P; Kufe DW; Anderson KC
Br J Haematol; 2004 May; 125(3):343-52. PubMed ID: 15086415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
